The US Supreme Court’s decision to continue allowing wide access to a drug that causes abortion prompted a federal appeals court to order supplemental briefing in a similar case.
The US Court of Appeals for the Ninth Circuit on Thursday told states to address Food & Drug Administration v. Alliance for Hippocratic Medicine, and how it affected the issues being considered by the appeals court, including standing.
The Supreme Court held Thursday that a group of Christian, anti-abortion doctors and an association that represents them didn’t have standing to pursue a challenge to FDA’s regulation of mifepristone. The narrow ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.